Cargando…

LB5. Safety of In Utero Antiretroviral (ARV) Exposure: Neurologic Outcomes in HIV-Exposed, Uninfected Children

BACKGROUND: Antiretroviral therapy for pregnant women with HIV has dramatically decreased perinatal transmission of HIV, but concerns remain regarding adverse neurologic outcomes from possible mitochondrial dysfunction or other mechanisms in children exposed in utero to antiretroviral (ARV) medicati...

Descripción completa

Detalles Bibliográficos
Autores principales:	Crowell, Claudia S, Williams, Paige, Yildirim, Cenk, Van Dyke, Russell, Smith, Renee, Chadwick, Ellen G, Seage, George, Hazra, Rohan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2018
Materias:	Abstracts
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6254030/ http://dx.doi.org/10.1093/ofid/ofy229.2179

Ejemplares similares

364. Association of Maternal ARV Use with Microcephaly in HIV-Exposed Uninfected Children
por: Williams, Paige L, et al.
Publicado: (2019)

Disclosing in utero HIV/ARV exposure to the HIV-exposed uninfected adolescent: is it necessary?
por: Jao, Jennifer, et al.
Publicado: (2016)

The PHACS SMARTT Study: Assessment of the Safety of In Utero Exposure to Antiretroviral Drugs
por: Van Dyke, Russell B., et al.
Publicado: (2016)

Surviving and Thriving—Shifting the Public Health Response to HIV-Exposed Uninfected Children: Report of the 3rd HIV-Exposed Uninfected Child Workshop
por: Slogrove, Amy L., et al.
Publicado: (2018)

The Burden of Oral Disease among Perinatally HIV-Infected and HIV-Exposed Uninfected Youth
por: Moscicki, Anna-Barbara, et al.
Publicado: (2016)

Differences in Growth of HIV-exposed Uninfected Infants in Ethiopia According to Timing of In-utero Antiretroviral Therapy Exposure
por: Ejigu, Yohannes, et al.
Publicado: (2020)

Effect of in utero exposure to HIV and antiretroviral drugs on growth in HIV-exposed uninfected children: a systematic review and meta-analysis protocol
por: Ekali, Gabriel L, et al.
Publicado: (2019)

Cancer risk among HIV-exposed uninfected children in the United States
por: Horner, Marie-Josèphe, et al.
Publicado: (2023)

2571. Higher Rates of Hospitalization and Infection-Related Hospitalization Among HIV-Exposed Uninfected Infants Compared with HIV Unexposed Uninfected Infants in the United States
por: Labuda, Sarah M, et al.
Publicado: (2018)

Cardiac and mitochondrial function in HIV-uninfected fetuses exposed to antiretroviral treatment
por: García-Otero, Laura, et al.
Publicado: (2019)

Antiretroviral Prescribing Practices Among Pregnant Women Living With HIV in the United States, 2008-2017
por: Powis, Kathleen M., et al.
Publicado: (2019)

Environmental Risk Characterization of an Antiretroviral (ARV) Lamivudine in Ecosystems
por: Omotola, Elizabeth Oyinkansola, et al.
Publicado: (2021)

Genetically determined ancestry is more informative than self-reported race in HIV-infected and -exposed children
por: Spector, Stephen A., et al.
Publicado: (2016)

CD4(+) and viral load outcomes of antiretroviral therapy switch strategies after virologic failure of combination antiretroviral therapy in perinatally HIV-infected youth in the United States
por: Fairlie, Lee, et al.
Publicado: (2015)

Safety of Pediatric HIV Elimination: The Growing Population of HIV- and Antiretroviral-Exposed but Uninfected Infants
por: Mofenson, Lynne M., et al.
Publicado: (2014)

Growth patterns of infants with in- utero HIV and ARV exposure in Cape Town, South Africa and Lusaka, Zambia
por: Nyemba, Dorothy C., et al.
Publicado: (2022)

The role of internalised HIV stigma in disclosure of maternal HIV serostatus to children perinatally HIV‐exposed but uninfected: a prospective study in the United States
por: Davtyan, Mariam, et al.
Publicado: (2023)

HIV-Exposed Uninfected Infants in Zimbabwe: Insights into Health Outcomes in the Pre-Antiretroviral Therapy Era
por: Evans, Ceri, et al.
Publicado: (2016)

COVID-19 pandemic and antiretrovirals (ARV) availability in Nigeria: recommendations to prevent shortages
por: Dada, David Adelekan, et al.
Publicado: (2020)

Patent Pooling for Promoting Access to Antiretroviral Drugs (ARVs) – A Strategic Option for India
por: Satyanarayana, Kanikaram, et al.
Publicado: (2010)

Adverse drug reactions to antiretroviral therapy (ARVs): incidence, type and risk factors in Nigeria
por: Eluwa, George I, et al.
Publicado: (2012)

Early neurodevelopment of HIV-exposed uninfected children in the era of antiretroviral therapy: a systematic review and meta-analysis
por: Wedderburn, Catherine J, et al.
Publicado: (2022)

The Immune System of HIV-Exposed Uninfected Infants
por: Abu-Raya, Bahaa, et al.
Publicado: (2016)

Unmasking the vulnerabilities of uninfected children exposed to HIV
por: Ramokolo, Vundli, et al.
Publicado: (2019)

New ARV drugs
por: Gulick, Roy
Publicado: (2014)

Correction: Adverse drug reactions to antiretroviral therapy (ARVs): incidence, type and risk factors in Nigeria
por: Eluwa, George I, et al.
Publicado: (2012)

Antiretroviral (ARV) Therapy in Resource Poor Countries: What do we Need in Real Life?
por: Castelli, Francesco, et al.
Publicado: (2010)

Antiretroviral drug resistance and viral tropism in HIV-1 CRF06_cpx infected patients failing antiretroviral (ARV) therapy
por: Pauskar, Merit, et al.
Publicado: (2014)

2261. Phosphaturia in HIV-Exposed Uninfected Neonates Associated With Maternal Use of Tenofovir Disoproxil Fumarate in Late Pregnancy
por: Purswani, Murli, et al.
Publicado: (2018)

Outcome of HIV-exposed uninfected children undergoing surgery
por: Karpelowsky, Jonathan S, et al.
Publicado: (2011)

Sulfamethoxazole Levels in HIV-Exposed Uninfected Ugandan Children
por: Kasule, Jingo, et al.
Publicado: (2018)

Analysis of the TCR Repertoire in HIV-Exposed but Uninfected Infants
por: Gabriel, Benjamin, et al.
Publicado: (2019)

Neurodevelopment of children who are HIV‐exposed and uninfected in Kenya
por: Bulterys, Michelle A., et al.
Publicado: (2023)

Development of long-acting ARV’s
por: Boffito, Marta
Publicado: (2014)

Long-Term Persistence of Mitochondrial DNA Instability in HIV-Exposed Uninfected Children during and after Exposure to Antiretroviral Drugs and HIV
por: Desquiret-Dumas, Valérie, et al.
Publicado: (2022)

Survival and health of children who are HIV-exposed uninfected: study protocol for the CHERISH (Children HIV-Exposed Uninfected - Research to Inform Survival and Health) dynamic, prospective, maternal-child cohort study
por: Slogrove, Amy L, et al.
Publicado: (2023)

Trends in Decline of Antiretroviral Resistance among ARV-Experienced Patients in the HIV Outpatient Study: 1999–2008
por: Buchacz, Kate, et al.
Publicado: (2012)

Age-specific associations with dental caries in HIV-infected, exposed but uninfected and HIV-unexposed uninfected children in Nigeria
por: Akhigbe, Paul, et al.
Publicado: (2022)

Neurological Findings in Children without Congenital Microcephaly Exposed to Zika Virus in Utero: A Case Series Study
por: Abtibol-Bernardino, Marília Rosa, et al.
Publicado: (2020)

Early structural brain development in infants exposed to HIV and antiretroviral therapy in utero in a South African birth cohort
por: Wedderburn, Catherine J., et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_jd2n0rtbe88ilerdv9vqcbopru